Antibiotics as a treatment for dementia
CA 2391596 A1 · Owner: Molloy, David William · Inventors: Molloy, David William
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
We have shown in a double blind placebo controlled study over one a one year period that treatment with the antibiotics rifampicin and doxycycline for three months significantly reduced the rate of cognitive decline in treated, subjects compared to controls at one year. Subjects were treated for three months and the followed for one year. We found that the subjects treated with the antibiotics had a significant decline in their rate of progression at six months and this was also present at one year. This data suggests that antibiotics slowed the rate of progress of these subjects with dementia. This effect suggests that some antibiotics have a disease-modifying effect on dementia and/or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 11, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.